Evidence map›Paper›PMID 36980235›Full record

ArticleCells2023

Interaction of a Novel Alternatively Spliced Variant of

Ru-Huei Fu, Syuan-Yu Hong, Chia-Wen Tsai, Shih-Ping Liu, Shao-Chih Chiu, Meng-Zhen Wu, Woei-Cherng Shyu, Shinn-Zong Lin

Open access · goldFull text read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cells, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 5 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Ru-Huei FuGraduate Institute of Biomedical Sciences, China Medical University, Taichung 40402, Taiwan.ORCID 0000-0001-9367-1759
Syuan-Yu HongGraduate Institute of Biomedical Sciences, China Medical University, Taichung 40402, Taiwan.
Chia-Wen TsaiDepartment of Nutrition, China Medical University, Taichung 40402, Taiwan.
Shih-Ping LiuGraduate Institute of Biomedical Sciences, China Medical University, Taichung 40402, Taiwan.
Shao-Chih ChiuGraduate Institute of Biomedical Sciences, China Medical University, Taichung 40402, Taiwan.
Meng-Zhen WuGraduate Institute of Biomedical Sciences, China Medical University, Taichung 40402, Taiwan.
Woei-Cherng ShyuGraduate Institute of Biomedical Sciences, China Medical University, Taichung 40402, Taiwan.
Shinn-Zong LinBuddhist Tzu Chi Bioinnovation Center, Tzu Chi Foundation, Hualien 97002, Taiwan.ORCID 0000-0002-4601-9933
China Medical University · TWTzu Chi Foundation · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Glioblastoma (GBM) is a primary brain tumor of unknown etiology. It is extremely aggressive, incurable and has a short average survival time for patients. Therefore, understanding the precise molecular mechanisms of this diseases is essential to establish effective treatments. In this study, we cloned and sequenced a splice variant of the hydroxysteroid 11-β dehydrogenase 1 like gene (

Indexed as

11-beta-Hydroxysteroid Dehydrogenase Type 1Brain NeoplasmsGlioblastomaUbiquitin-Protein LigasesAnimalsCarcinogenesisCevanesHumansMiceProtein Isoforms11-beta-Hydroxysteroid Dehydrogenase Type 1CevanesHSD11B1 protein, humanparkin proteinpeiminineProtein IsoformsUbiquitin-Protein Ligasesalternative splicingglioblastomahydroxysteroid 11-β-dehydrogenase 1 like gene (HSD11B1L)invasionmigrationparkinpeiminineproliferation

Identifiers

PMID36980235
PMCPMC10047488
OpenAlexW4324360425

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read83
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.